Evidence map›Paper›PMID 33625661›Full record

ArticleInternal and emergency medicine2021

An integrated emergency department/hospital at home model in mild COVID-19 pneumonia: feasibility and outcomes after discharge from the emergency department.

Pere Llorens, Oscar Moreno-Pérez, Begoña Espinosa, Tamara García, Ana Belén Payá, Sonia Sola, Francisca Molina, Francisco Román, Inmaculada Jiménez, Sergio Guzman and 7 more

Open access · bronzeAbstract read
In one paragraph

Article in Internal and emergency medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Observational
  3. Article
  4. Review
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 2 institutions in 1 country.

Pere Llorens *Emergency Department, Institute of Sanitary and Biomedical Research (ISABIAL), Alicante General University Hospital, Alicante, s/n, Maestro Alonso Street, 03010, Alicante, Spain.
Oscar Moreno-Pérez *Endocrinology and Nutrition Department, Institute of Sanitary and Biomedical Research (ISABIAL), Alicante General University Hospital, Alicante, Alicante, Spain.
Begoña EspinosaEmergency Department, Institute of Sanitary and Biomedical Research (ISABIAL), Alicante General University Hospital, Alicante, s/n, Maestro Alonso Street, 03010, Alicante, Spain.
Tamara GarcíaEmergency Department, Institute of Sanitary and Biomedical Research (ISABIAL), Alicante General University Hospital, Alicante, s/n, Maestro Alonso Street, 03010, Alicante, Spain.
Ana Belén PayáEmergency Department, Institute of Sanitary and Biomedical Research (ISABIAL), Alicante General University Hospital, Alicante, s/n, Maestro Alonso Street, 03010, Alicante, Spain.
Sonia SolaEmergency Department, Institute of Sanitary and Biomedical Research (ISABIAL), Alicante General University Hospital, Alicante, s/n, Maestro Alonso Street, 03010, Alicante, Spain.
Francisca MolinaEmergency Department, Institute of Sanitary and Biomedical Research (ISABIAL), Alicante General University Hospital, Alicante, s/n, Maestro Alonso Street, 03010, Alicante, Spain.
Francisco RománEmergency Department, Institute of Sanitary and Biomedical Research (ISABIAL), Alicante General University Hospital, Alicante, s/n, Maestro Alonso Street, 03010, Alicante, Spain.
Inmaculada JiménezEmergency Department, Institute of Sanitary and Biomedical Research (ISABIAL), Alicante General University Hospital, Alicante, s/n, Maestro Alonso Street, 03010, Alicante, Spain.
Sergio GuzmanEmergency Department, Institute of Sanitary and Biomedical Research (ISABIAL), Alicante General University Hospital, Alicante, s/n, Maestro Alonso Street, 03010, Alicante, Spain.
Adriana Gil-RodrigoEmergency Department, Institute of Sanitary and Biomedical Research (ISABIAL), Alicante General University Hospital, Alicante, s/n, Maestro Alonso Street, 03010, Alicante, Spain. adri.gil.rodrigo@gmail.com.ORCID 0000-0003-0106-4324
Bárbara Peña-PardoEmergency Department, Institute of Sanitary and Biomedical Research (ISABIAL), Alicante General University Hospital, Alicante, s/n, Maestro Alonso Street, 03010, Alicante, Spain.
Esperanza MerinoUnit of Infectious Diseases, Alicante General University Hospital, Alicante Institute of Sanitary and Biomedical Research (ISABIAL), Alicante, Spain.
Joan GilPneumology Department, Alicante General University Hospital, Alicante Institute of Sanitary and Biomedical Research (ISABIAL), Alicante, Spain.
David San-InocencioHospital-at-Home Unit, Department, Alicante General University Hospital, Alicante Institute of Sanitary and Biomedical Research (ISABIAL), Alicante, Spain.
Mariano AndrésClinical Medicine Department, Miguel Hernandez University, Elche, Spain.
José Sánchez-PayáPreventive Department, Alicante General University Hospital, Alicante Institute of Sanitary and Biomedical Research (ISABIAL), Alicante, Spain.
Hospital General Universitario de Alicante Doctor Balmis · ESUniversitat de Miguel Hernández d'Elx · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To evaluate the effectiveness of an integrated emergency department (ED)/hospital at home (HH) medical care model in mild COVID-19 pneumonia and evaluate baseline predictors of major outcomes and potential savings. Retrospective cohort study with patients evaluated for COVID-19 pneumonia in the ED, from March 3 to April 30, 2020. All of them were discharged home and controlled by HH. The main outcomes were ED revisit and the need for deferred hospital admission (protocol failure). Outcome predictors were analyzed by simple logistic regression model (OR; 95% CI). Potential savings of this medical care model were estimated. Of the 377 patients attended in the ED, 109 were identified as having mild pneumonia and were included in the ED/HH medical care model. Median age was 50.0 years, 52.3% were males and 57.8% had Charlson index ≥ 1. The median HH stay was 8 (IQR 3.7-11) days. COVID-19-related ED revisit was 19.2% (n = 21) within 6 days (IQR 3-12.5) after discharge from ED. Overall protocol failure (deferred hospital admission) was 6.4% (n = 7), without ICU admission. The ED/HH model provided potential cost savings of 77% compared to traditional stay, due to the costs of home care entails 23% of the expenses generated by a conventional hospital stay. 789 days of hospital stay were avoided by HH, rather than hospital admission. An innovative ED/HH model for selected patients with mild COVID-19 pneumonia is feasible, safe and effective. Less than 6.5% of patients requiring deferred hospital admission and potential savings were generated due to hospitalization.

Indexed as

AftercareAgedCOVID-19Feasibility StudiesHumansLength of StayMaleMiddle AgedOutcome Assessment, Health CarePatient DischargePatient ReadmissionRetrospective StudiesTime FactorsCOVID-19Emergency departmentHospital based home caresPneumonia

Identifiers

PMID33625661
PMCPMC7903217
OpenAlexW3131836006

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.